[PRESSWIRE] BOCA RATON, Florida, Aug. 21, 2017 -- Caret Pharma, a subsidiary of Caret Group, today announced it has entered into an agreement with Moberg Pharma AB to acquire the assets of Fiber Choice®, a line of innovative dietary supplements containing 100% natural, prebiotic fiber.
Press Releases in Pharmaceuticals
[PRESSWIRE] DUBLIN, Aug. 18, 2017 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced an offering by Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), of $500 million aggregate principal amount of exchangeable senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
[PRESSWIRE] LONDON, August 9, 2017 -- The only conference in Europe dedicated to finding the right strategy to comply with the multitude of regulations governing the development of combination products.
[PRESSWIRE] DUBLIN, May 23, 2017 -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced that Emmy®and Tony® award-winning actress and singer, Kristin Chenoweth will kick off the "Less Red, More You" campaign today at an exclusive event in New York City.
[PRESSWIRE] BRUSSELS, May 16, 2017 -- Systech International, a global technology solutions leader for the pharmaceutical industry, is proud to announce its upcoming serialisation webinar titled "The Clock is Ticking: Overcoming the Challenges of Implementing Serialisation in the EU"on 24 May 2017.
[PRESSWIRE] Calgary, Alberta, Canada - 27 March, 2017 -- Developed by AOR, Curcumin Ultra combines superior free-form curcumin (CurQfen®) with water-soluble turmeric polysaccharides (Turmacin®) for a long lasting synergistic effect for inflammation and pain relief.
[PRESSWIRE] SYDNEY, March 6, 2017 --Australian oncology-focused biotechnology company Novogen Limited (ASX: NRT; NASDAQ: NVGN) is pleased to announce that it has been awarded a grant of up to A$3m over three years under the Cooperative Research Centre Project (CRC-P) scheme managed by the Australian Department of Industry Innovation and Science (DIIS).
[PRESSWIRE] WESTERHAM, England, January 16, 2017 -- A major investment in the leading source of drug discovery industry information - Drug Target Review - has led to a comprehensive relaunch.
[PRESSWIRE] INDIANAPOLIS, January 5, 2017 -- Eli Lilly and Company (NYSE: LLY) today announced a series of changes to its organization and leadership structure to better align them with the company's growth opportunities.
[PRESSWIRE] BENGALURU, October 19, 2016 -- Jubilant Biosys is proud to announce the addition of Agilent Technologies' RapidFire/MS screening technology to its Integrated Drug Discovery Platform.